Original articles
Han Xiao, Rui Zhang, Xiaobo Fan, Xinglu Jiang, Mingyuan Zou, Xuejiao Yan, Haiping Hao, Guoqiu Wu. Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy[J]. Acta Pharmaceutica Sinica B, 2022, 12(3): 1473-1486

Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy
Han Xiaoa,d, Rui Zhanga, Xiaobo Fana, Xinglu Jianga, Mingyuan Zoua, Xuejiao Yanf, Haiping Haoe, Guoqiu Wub,c
a. Medical School, Southeast University, Nanjing 210009, China;
b. Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China;
c. Jiangsu Provincial Key Laboratory of Critical Care Medicine, Southeast University, Nanjing 210009, China;
d. Department of Clinical Laboratory, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China;
e. State Key Laboratory of Natural Medicines, Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 21009, China;
f. Department of Cardiology, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China
Abstract:
The development of nanomedicine has recently achieved several breakthroughs in the field of cancer treatment; however, biocompatibility and targeted penetration of these nanomaterials remain as limitations, which lead to serious side effects and significantly narrow the scope of their application. The self-assembly of intermediate filaments with arginine-glycine-aspartate (RGD) peptide (RGD-IFP) was triggered by the hydrophobic cationic molecule 7-amino actinomycin D (7-AAD) to synthesize a bifunctional nanoparticle that could serve as a fluorescent imaging probe to visualize tumor treatment. The designed RGD-IFP peptide possessed the ability to encapsulate 7-AAD molecules through the formation of hydrogen bonds and hydrophobic interactions by a one-step method. This fluorescent nanoprobe with RGD peptide could be targeted for delivery into tumor cells and released in acidic environments such as endosomes/lysosomes, ultimately inducing cytotoxicity by arresting tumor cell cycling with inserted DNA. It is noteworthy that the RGD-IFP/7-AAD nanoprobe tail-vein injection approach demonstrated not only high tumor-targeted imaging potential, but also potent antitumor therapeutic effects in vivo. The proposed strategy may be used in peptide-driven bifunctional nanoparticles for precise imaging and cancer therapy.
Key words:    Nanoprobe    7-Amino actinomycin D    Intermediate filament protein    Tumor image    Antitumor therapy    Integrin αvβ3   
Received: 2021-05-13     Revised: 2021-06-22
DOI: 10.1016/j.apsb.2021.07.020
Funds: This work was supported by the National Natural Science Foundation of China (No. 81603016, 81773624, 81900453), the Natural Science Foundation of Jiangsu Province (No. BK20160706, BE2017746, China), the National Science and Technology Major Project (2018ZX09301026-005, 2020ZX09201015, China).
Corresponding author: Haiping Hao,E-mai:hhp_770505@hotmail.com;Guoqiu Wu,E-mai:101008404@seu.edu.cn     Email:hhp_770505@hotmail.com;101008404@seu.edu.cn
Author description:
Service
PDF(KB) Free
Print
0
Authors
Han Xiao
Rui Zhang
Xiaobo Fan
Xinglu Jiang
Mingyuan Zou
Xuejiao Yan
Haiping Hao
Guoqiu Wu

References:
[1] Choi EW, Nayak LV, Bates PJ. Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides. Nucleic Acids Res 2010; 38: 1623-1635
[2] Zheng S, Zhang Z, Qu Y, Zhang XJ, Guo HB, Shi XJ, et al. Radiopharmaceuticals and fluorescein sodium mediated triple-modality molecular imaging allows precise image-guided tumor surgery. Adv Sci (Weinh) 2019; 6: 1900159
[3] Wang YS, Jiang LP, Zhang YW, Lu YM, Li JN, Wang H, et al. Fibronectin-targeting and cathepsin B-activatable theranostic nanoprobe for MR/fluorescence imaging and enhanced photodynamic therapy for triple negative breast cancer. ACS Appl Mater Interfaces 2020; 12: 33564-33574
[4] Yang YJ, He Y, Deng ZW, Li JC, Huang J, Zhong S. Intelligent nanoprobe: Acid-responsive drug release and in situ evaluation of its own therapeutic effect. Anal Chem 2020; 92: 12371-12378
[5] Yoo JW, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev 2011; 63: 1247-1256
[6] Yuan A, Qiu XF, Tang XL, Liu W, Wu JH, Hu YQ. Self-assembled PEG-IR-780-C13 micelle as a targeting, safe and highly-effective photothermal agent for in vivo imaging and cancer therapy. Biomaterials 2015; 51: 184-193
[7] Huang YZ, Jiang YF, Wang HY, Wang JX, Shin MC, Byun Y, et al. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev 2013; 65: 1299-1315
[8] Li XN, Schumann C, Albarqi HA, Lee CJ, Alani AWG, Bracha S, et al. A tumor-activatable theranostic nanomedicine platform for NIR fluorescence-guided surgery and combinatorial phototherapy. Theranostics 2018; 8: 767-784
[9] Sarkar S, Levi-Polyachenko N. Conjugated polymer nano-systems for hyperthermia, imaging and drug delivery. Adv Drug Deliv Rev 2020; 163-164:40-64
[10] Li WJ, Cai SH, Cai L, Li XK. Anti-apoptotic effect of hepatocyte growth factor from actinomycin D in hepatocyte-derived HL7702 cells is associated with activation of PI3K/Akt signaling. Toxicol Lett 2006; 165: 142-148
[11] Siboni RB, Nakamori M, Wagner SD, Struck AJ, Coonrod LA, Harriott SA, et al. Actinomycin D specifically reduces Eexpanded CUG repeat RNA in myotonic dystrophy models. Cell Rep 2015; 13: 2386-2394
[12] Stokke T, Holte H, Simland EB, Lie SO, Steen HB. Differential chromatin structure-dependent binding of 7-Aminoactinomycin D in normal and malignant bone marrow hematopoietic cells. Cancer Res 1992; 52: 5007-5012
[13] Kim D, Kim J, Park YI, Lee N, Hyeon T. Recent development of inorganic nanoparticles for Bbiomedical imaging. ACS Cent Sci 2018; 4: 324-336
[14] Cohen S, Margel S. Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancer. J Nanobiotechnology 2012; 10: 36-44
[15] Negahdaripour M, Golkar N, Hajighahramani N, Kianpour S, Nezafat N, Ghasemi Y. Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biotechnol Adv 2017; 35: 575-596
[16] Sun BF, Deng C, Meng FH, Zhang J, Zhong YZ. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials. Acta Biomater 2016; 45: 223-233
[17] Kaus-Drobek M, Mucke N, Szczepanowski RH, Wedig T, Czarnocki-Cieciura M, Polakowska M, et al. Vimentin S-glutathionylation at Cys328 inhibits filament elongation and induces severing of mature filaments in vitro. FEBS J 2020; 287: 5304-5322
[18] Brown N, Lei JT, Zhan CD, Shimon LJW, Adler-Abramovich L, Wei GH, et al. Structural polymorphism in a self-assembled tri-aromatic peptide system. ACS Nano 2018; 12: 3253-3262
[19] Avitabile C, Diaferia C, Ventura BD, Mercurio FA, Leone M, Roviello V, et al. Self-assembling of fmoc-GC peptide nucleic acid dimers into highly fluorescent aggregates. Chem Eur J 2018; 24: 4729-4735
[20] Demircioglu F, Hodivala-Dilke K. alphavbeta3 Integrin and tumour blood vessels-learning from the past to shape the future. Curr Opin Cell Biol 2016; 42: 121-127
[21] Huang R, Rofstad EK. Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma. J Exp Clin Cancer Res 2018; 37: 92
[22] Chen HJ, Niu G, Wu H, Chen XY. Clinical application of radiolabeled RGD peptides for PET imaging of integrin alphavbeta3. Theranostics 2016; 6: 78-92
[23] Zembruski NC, Stache V, Haefeli WE, Weiss J. 7-Aminoactinomycin D for apoptosis staining in flow cytometry. Anal Biochem 2012; 429: 79-81
[24] Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biology 2001; 2: research0041
[25] Almaqwashi AA, Zhou W, Naufer MN, Riddell IA, Yilmaz OH, Lippard SJ, et al. DNA intercalation facilitates efficient DNA-targeted covalent binding of phenanthriplatin. J Am Chem Soc 2019; 141: 1537-1545
[26] Veselinovic J, Li ZD, Daggumati P, Seker E. Electrically guided DNA immobilization and multiplexed DNA detection with nanoporous gold electrodes. Nanomaterials (Basel) 2018; 8: 351
[27] Li CX, Wang WL, Xi YW, Wang JW, Chen JF, Yun J, et al. Design, preparation and characterization of cyclic RGDfK peptide modified poly(ethylene glycol)-block-poly(lactic acid) micelle for targeted delivery. Mater Sci Eng C Mater Biol Appl 2016; 64: 303-309
[28] Camunas-Soler J, Frutos S, Bizarro CV, Lorenzo Sd, Fuentes-Perez ME, Ramsch R, et al. Electrostatic binding and hydrophobic collapse of peptide-nucleic acid aggregates quantified using force spectroscopy. Acs Nano 2013; 7: 5102-5113
[29] Liang PQ, Zheng JJ, Dai SL, Wang JY, Zhang ZQ, Kang T, et al. pH triggered re-assembly of nanosphere to nanofiber: The role of peptide conformational change for enhanced cancer therapy. J Control Release 2017; 260: 22-31
[30] Habtemariam B, Anisimov VM, MacKerell Jr AD. Cooperative binding of DNA and CBFbeta to the Runt domain of the CBFalpha studied via MD simulations. Nucleic Acids Res 2005; 33: 4212-4222
[31] Wagoner JA, Dill KA. Opposing pressures of speed and efficiency guide the evolution of molecular machines. Mol Biol Evol 2019; 36: 2813-2822
[32] Miller Y, Ma B, Nussinov R. Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states. Proc Natl Acad Sci U S A 2010; 107: 9490-9495
[33] Liu R, Hu C, Yang YY, Zhang JQ, Gao HL. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 2019; 9: 410-420
[34] Wang H, Agarwal P, Zhao G, Ji G, Jewell CM, Fisher JP, et al. Overcoming ovarian cancer drug resistance with a cold responsive nanomaterial. ACS Cent Sci 2018; 4: 567-581
[35] Yu GC, Zhao XL, Zhou J, Mao ZW, Huang XL, Wang ZT, et al. Supramolecular polymer-based nanomedicine: High therapeutic performance and negligible long-term immunotoxicity. J Am Chem Soc 2018; 140: 8005-8019
[36] Wang S, Yu G, Wang ZT, Jacobson O, Tian R, Lin LS, et al. Hierarchical tumor microenvironment-responsive nanomedicine for programmed delivery of chemotherapeutics. Adv Mater 2018: e1803926
[37] Li SK, Zou QL, Li YX, Yuan CQ, Xing RR, Yan XH. Smart peptide-based supramolecular photodynamic metallo-nanodrugs designed by multicomponent coordination self-assembly. J Am Chem Soc 2018; 140: 10794-10802
[38] Gaforio JJ, Serrano MJ, Algarra I, Ortega E, Cienfuegos GA d. Phagocytosis of apoptotic cells assessed by flow cytometry using 7-aminoactinomycin D. Cytometry 2002; 49: 8-11
[39] Asampille G, Verma BK, Swain M, Shettar A, Rosenzweig SA, Kondaiah P, et al. An ultra-stable redox-controlled self-assembling polypeptide nanotube for targeted imaging and therapy in cancer. J Nanobiotechnology 2018; 16: 101
[40] Singh D, Vishnoi T, Kumar A. Effect of alpha-ketoglutarate on growth and metabolism of cells cultured on three-dimensional cryogel matrix. Int J Biol Sci 2013; 9: 521-530
[41] Pasparakis G, Manouras T, Vamvakaki M, Argitis P. Harnessing photochemical internalization with dual degradable nanoparticles for combinatorial photo-chemotherapy. Nat Commun 2014; 5: 3623
[42] Wang H, Agarwal P, Xiao YC, Peng H, Zhao ST, Liu XY, et al. A nano-in-micro system for enhanced stem cell therapy of ischemic diseases. ACS Cent Sci 2017; 3: 875-885
[43] Fan L, Zhang SL, Zhang CY, Yin C, Chu ZQ, Song CJ, et al. Multidrug resistance in cancer circumvented using a cytosolic drug reservoir. Adv Sci (Weinh) 2018; 5: 1700289
[44] Yang LN, Sun J, Liu Q, Zhu RR, Yang QN, Hua JH, et al. Synergetic functional nanocomposites enhance immunotherapy in solid tumors by remodeling the immunoenvironment. Adv Sci (Weinh) 2019; 6: 1802012
[45] Chauhan K, Hernandez-Meza JM, Rodriguez-Hernandez AG, Juarez-Moreno K, Sengar P, Vazquez-Duhalt R. Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer. J Nanobiotechnology 2018; 16: 17
[46] Wang HX, Chen JM, Xu C, Shi LL, Tayier M, Zhou JH, et al. Cancer nanomedicines stabilized by pi-pi stacking between heterodimeric prodrugs enable exceptionally high drug loading capacity and safer delivery of drug combinations. Theranostics 2017; 7: 3638-3652
[47] Li YK, Li YH, Zhang X, Xu XH, Zhang ZJ, Hu C, et al. Supramolecular PEGylated dendritic systems as pH/redox dual-responsive theranostic nanoplatforms for platinum drug delivery and NIR imaging. Theranostics 2016; 6: 1293-1305
[48] Amit M, Abdelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, et al. Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma. J Clin Oncol 2019; 37: 504-512
Similar articles: